logo

IPO

IPO
Gainers & Losers

IPO Synopsis

Onyx Biotec Ltd
Initial public offer of upto 48,10,000 equity shares of face value of Rs. 10/- each ("Equity Shares") of the company at an issue price of Rs. 61 per equity share (including a share premium of Rs. 51 per equity share) for cash, aggregating up to Rs. 29.34 crores ("Public Issue") out of which 2,44,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 61 per equity share for cash, aggregating Rs. 1.49 crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. issue of 45,66,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 61 per equity share for cash, aggregating up to Rs. 27.85 crores is hereinafter referred to as the "Net Issue". The public issue and net issue will constitute 26.53 % and 25.18 % respectively of the post-issue paid-up equity share capital of the company.
Issue
Opens On Closes On
13-Nov-24 18-Nov-24
Money Payable On
Application Allotment
61.00 0.00
Minimum Application for shares in Nos : 2000 Further Multiples of : 2000
Cr Lead Managers to the Issue
Project Cost (.Cr) 0.00 Horizon Management Pvt Ltd
Project Financed through Current Offer (.Cr) 29.34  
Post Issue Equity Share Capital (.Cr) 18.13
Issue Price () 61.00
Projects
Upgradation of existing mfg unit 1 to mfg large volume parentals for intravenous use
Setting up a high-speed cartooning packaging line at existing mfg unit 2 for Dry Powder Injections
Prepayment or repayment of all or a portion of certain loans availed by the company
General corporate purposes
Promoted By
Sanjay Jain
Naresh Kumar
Fateh Pal Singh
Listing At
NSE - SME
Registrar to the Issue
Mas Services Limited